Regulus Therapeutics Inc. 4
4 · Regulus Therapeutics Inc. · Filed Jun 23, 2017
Insider Transaction Report
Form 4
Deeg Mark Albert
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-06-22+100,000→ 100,000 totalExercise: $0.99Exp: 2017-06-21→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest on June 22, 2018 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on June 22, 2021.